🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/01/1992 | 24,09 | 24,63 | 24,07 | 24,63 | +2,23% | 2,31% | 5.188.229 |
| 21/01/1992 | 24,47 | 24,47 | 23,70 | 24,09 | -1,30% | 3,17% | 6.626.294 |
| 20/01/1992 | 24,49 | 24,69 | 24,37 | 24,41 | -0,16% | 1,30% | 5.531.554 |
| 17/01/1992 | 24,03 | 24,45 | 24,03 | 24,45 | -0,24% | 1,74% | 12.345.859 |
| 16/01/1992 | 24,05 | 24,61 | 23,91 | 24,51 | -1,28% | 2,89% | 14.335.382 |
| 15/01/1992 | 25,47 | 25,49 | 24,73 | 24,83 | -2,50% | 2,97% | 9.079.872 |
| 14/01/1992 | 25,41 | 25,50 | 25,05 | 25,47 | +0,00% | 1,80% | 7.145.683 |
| 13/01/1992 | 25,88 | 25,90 | 25,29 | 25,47 | -1,76% | 2,38% | 6.233.923 |
| 10/01/1992 | 26,34 | 26,44 | 25,88 | 25,92 | -2,10% | 2,11% | 4.049.472 |
| 09/01/1992 | 26,54 | 26,60 | 26,28 | 26,48 | -0,15% | 1,20% | 4.712.227 |
| 08/01/1992 | 26,44 | 26,66 | 26,40 | 26,52 | +0,00% | 0,98% | 4.663.181 |
| 07/01/1992 | 26,48 | 26,54 | 26,36 | 26,52 | -0,30% | 0,68% | 3.459.029 |
| 06/01/1992 | 26,84 | 26,90 | 26,46 | 26,60 | -0,96% | 1,63% | 5.682.466 |
| 03/01/1992 | 26,34 | 27,00 | 26,34 | 26,86 | +1,50% | 2,49% | 4.809.062 |
| 02/01/1992 | 26,40 | 26,52 | 26,08 | 26,46 | -0,08% | 1,66% | 5.141.698 |
| 31/12/1991 | 26,42 | 26,56 | 26,10 | 26,48 | +0,15% | 1,73% | 5.490.682 |
| 30/12/1991 | 26,26 | 26,52 | 26,18 | 26,44 | +0,53% | 1,29% | 4.760.645 |
| 27/12/1991 | 26,06 | 26,36 | 25,88 | 26,30 | +0,76% | 1,83% | 3.272.275 |
| 26/12/1991 | 25,27 | 26,20 | 25,23 | 26,10 | +3,30% | 3,86% | 2.911.344 |
| 24/12/1991 | 25,41 | 25,60 | 25,25 | 25,27 | -0,70% | 1,41% | 3.025.157 |
| 23/12/1991 | 24,59 | 25,49 | 24,59 | 25,45 | +3,39% | 3,64% | 5.054.923 |
| 20/12/1991 | 24,59 | 24,71 | 24,43 | 24,61 | +0,81% | 1,13% | 9.938.184 |
| 19/12/1991 | 24,11 | 24,47 | 24,05 | 24,41 | +0,90% | 1,73% | 3.489.840 |
| 18/12/1991 | 23,99 | 24,23 | 23,97 | 24,19 | +0,50% | 1,08% | 3.367.853 |
| 17/12/1991 | 23,84 | 24,09 | 23,74 | 24,07 | +0,92% | 1,50% | 3.212.539 |
| 16/12/1991 | 23,70 | 23,99 | 23,64 | 23,86 | +0,67% | 1,51% | 2.494.450 |
| 13/12/1991 | 23,93 | 23,99 | 23,68 | 23,70 | -0,17% | 1,33% | 3.695.458 |
| 12/12/1991 | 23,80 | 23,89 | 23,54 | 23,74 | -0,17% | 1,50% | 3.528.826 |
| 11/12/1991 | 24,01 | 24,05 | 23,50 | 23,78 | -0,83% | 2,32% | 5.043.605 |
| 10/12/1991 | 24,03 | 24,17 | 23,82 | 23,97 | -0,41% | 1,49% | 3.729.413 |